EP0973394A4 - Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof - Google Patents
Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereofInfo
- Publication number
- EP0973394A4 EP0973394A4 EP97913847A EP97913847A EP0973394A4 EP 0973394 A4 EP0973394 A4 EP 0973394A4 EP 97913847 A EP97913847 A EP 97913847A EP 97913847 A EP97913847 A EP 97913847A EP 0973394 A4 EP0973394 A4 EP 0973394A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- helicobacter pylori
- vaccine compositions
- amino acid
- nucleic acid
- acid sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73915096A | 1996-10-28 | 1996-10-28 | |
| US75973996A | 1996-12-06 | 1996-12-06 | |
| US89192897A | 1997-07-14 | 1997-07-14 | |
| US891928 | 1997-07-14 | ||
| PCT/US1997/019575 WO1998018323A1 (en) | 1996-10-28 | 1997-10-28 | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| US739150 | 2000-12-18 | ||
| US759739 | 2001-01-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0973394A1 EP0973394A1 (en) | 2000-01-26 |
| EP0973394A4 true EP0973394A4 (en) | 2005-03-30 |
Family
ID=27419246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP97913847A Withdrawn EP0973394A4 (en) | 1996-10-28 | 1997-10-28 | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973394A4 (en) |
| JP (1) | JP2001504329A (en) |
| KR (1) | KR20000052831A (en) |
| CN (1) | CN1235513A (en) |
| AR (1) | AR009600A1 (en) |
| AU (1) | AU734052B2 (en) |
| BR (1) | BR9712587A (en) |
| CA (1) | CA2265523A1 (en) |
| EE (1) | EE9900176A (en) |
| ID (1) | ID22065A (en) |
| IL (1) | IL129397A0 (en) |
| IS (1) | IS5005A (en) |
| NO (1) | NO991995L (en) |
| NZ (1) | NZ334568A (en) |
| PL (1) | PL333169A1 (en) |
| SA (1) | SA98180918A (en) |
| SK (1) | SK34699A3 (en) |
| TR (1) | TR199900940T2 (en) |
| WO (1) | WO1998018323A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995003824A1 (en) * | 1993-07-27 | 1995-02-09 | Csl Limited | Treatment of h. pylori associated gastroduodenal disease |
| US6406703B1 (en) | 1993-07-27 | 2002-06-18 | Csl Limited | Treatment of H. pylori associated gastroduodenal disease |
| DE19730425A1 (en) | 1997-07-16 | 1999-01-21 | Henkel Teroson Gmbh | Heat-curing laundry-resistant shell sealant |
| WO2000006743A2 (en) * | 1998-07-27 | 2000-02-10 | Connaught Laboratories Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| SE9901548D0 (en) * | 1999-04-29 | 1999-04-29 | Astra Ab | Helicobacter pylori antigens |
| GB9914945D0 (en) * | 1999-06-25 | 1999-08-25 | Smithkline Beecham Biolog | Novel compounds |
| AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
| CN101532001A (en) | 2000-03-08 | 2009-09-16 | 诺维信公司 | Variants with altered properties |
| GB0010371D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| GB0010370D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| US9359627B2 (en) | 2011-03-17 | 2016-06-07 | National University Corporation Mie University | Antibody production method |
| US10828358B2 (en) * | 2015-12-14 | 2020-11-10 | Technische Universität München | Helicobacter pylori vaccines |
| CN115724922B (en) * | 2022-07-19 | 2023-08-22 | 四川大学华西医院 | Helicobacter pylori vaccine recombinant protein antigen TonB, preparation method and application thereof |
| CN115581201A (en) * | 2022-08-26 | 2023-01-10 | 云南省农业科学院花卉研究所 | Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994016714A1 (en) * | 1993-01-19 | 1994-08-04 | Medicarb Ab | The use of a composition for the treatment of infections caused by helicobacter pylori |
-
1997
- 1997-10-28 CN CN97199233A patent/CN1235513A/en active Pending
- 1997-10-28 AR ARP970105002A patent/AR009600A1/en not_active Application Discontinuation
- 1997-10-28 CA CA002265523A patent/CA2265523A1/en not_active Abandoned
- 1997-10-28 JP JP52071098A patent/JP2001504329A/en active Pending
- 1997-10-28 AU AU50933/98A patent/AU734052B2/en not_active Ceased
- 1997-10-28 TR TR1999/00940T patent/TR199900940T2/en unknown
- 1997-10-28 ID IDW990160A patent/ID22065A/en unknown
- 1997-10-28 KR KR1019990703660A patent/KR20000052831A/en not_active Application Discontinuation
- 1997-10-28 IL IL12939797A patent/IL129397A0/en unknown
- 1997-10-28 EP EP97913847A patent/EP0973394A4/en not_active Withdrawn
- 1997-10-28 SK SK346-99A patent/SK34699A3/en unknown
- 1997-10-28 BR BR9712587-3A patent/BR9712587A/en not_active IP Right Cessation
- 1997-10-28 EE EEP199900176A patent/EE9900176A/en unknown
- 1997-10-28 NZ NZ334568A patent/NZ334568A/en unknown
- 1997-10-28 WO PCT/US1997/019575 patent/WO1998018323A1/en not_active Application Discontinuation
- 1997-10-28 PL PL97333169A patent/PL333169A1/en unknown
-
1998
- 1998-02-28 SA SA98180918A patent/SA98180918A/en unknown
-
1999
- 1999-03-18 IS IS5005A patent/IS5005A/en unknown
- 1999-04-27 NO NO991995A patent/NO991995L/en not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994016714A1 (en) * | 1993-01-19 | 1994-08-04 | Medicarb Ab | The use of a composition for the treatment of infections caused by helicobacter pylori |
Non-Patent Citations (5)
| Title |
|---|
| DATABASE EMBL 31 January 1997 (1997-01-31), AKOPYANTS, N.S. ET AL.: "Helicobacter pylori cosmid clone 36, complete sequence", XP002303939, Database accession no. AC000108 * |
| DATABASE UniProt 1 January 1998 (1998-01-01), TOMB, J.-F. ET AL.: "Outer membrane protein (Omp11)", Database accession no. O25218 * |
| JEAN-F. TOMB ET AL.: "The complete genome sequence of the gastric pathogen Helicobacter pylori", NATURE, vol. 389, 25 September 1997 (1997-09-25), pages 539 - 547, XP002303938 * |
| SCHMITT W ET AL: "GENETIC ANALYSIS OF THE HELICOBACTER PYLORI VACUOLATING CYTOTOXIN: STRUCTURAL SIMILARITIES WITH THE IGA PROTEASE TYPE OF EXPORTED PROTEIN", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, GB, vol. 12, no. 2, 1 April 1994 (1994-04-01), pages 307 - 319, XP000605827, ISSN: 0950-382X * |
| See also references of WO9818323A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TR199900940T2 (en) | 1999-09-21 |
| EP0973394A1 (en) | 2000-01-26 |
| AU734052B2 (en) | 2001-05-31 |
| JP2001504329A (en) | 2001-04-03 |
| KR20000052831A (en) | 2000-08-25 |
| IL129397A0 (en) | 2000-02-17 |
| NZ334568A (en) | 2000-04-28 |
| BR9712587A (en) | 1999-10-26 |
| CA2265523A1 (en) | 1998-05-07 |
| NO991995D0 (en) | 1999-04-27 |
| EE9900176A (en) | 1999-12-15 |
| SA98180918A (en) | 2005-12-03 |
| AU5093398A (en) | 1998-05-22 |
| PL333169A1 (en) | 1999-11-22 |
| NO991995L (en) | 1999-06-28 |
| AR009600A1 (en) | 2000-04-26 |
| WO1998018323A1 (en) | 1998-05-07 |
| SK34699A3 (en) | 2000-04-10 |
| ID22065A (en) | 1999-08-26 |
| IS5005A (en) | 1999-03-18 |
| CN1235513A (en) | 1999-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK165197A3 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics | |
| IL122340A0 (en) | Helicobacter pylori antigens and vaccine compositions | |
| HUP0100267A3 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| IL129397A0 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| IL129746A0 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| AU1698699A (en) | (helicobacter pylori) vaccine formulations | |
| AU1055497A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics | |
| ZA979672B (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof | |
| HUP9903843A3 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| HUP0000521A3 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| EP1019522A4 (en) | Compositions and methods for administering pneumococcal dna | |
| ZA9710971B (en) | Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof. | |
| ZA972715B (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof. | |
| HUP9900766A3 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics | |
| AU3066097A (en) | Methods for sequencing large nucleic acid segments and compositions for large sequencing projects | |
| ZA964869B (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics | |
| EP1071325A4 (en) | Compositions and methods for antigen-specific vaccination | |
| EE9900566A (en) | Vaccine compositions containing Helicobacter pylori FlgE polypeptide | |
| GB2290710B (en) | Protease from helicobacter pylori for use in vaccines/therapeutic compositions | |
| AU8048698A (en) | Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide | |
| RU99111594A (en) | HELICOBACTER PYLORI NUCLEIC ACID AND AMINO ACID SEQUENCES AND THEIR VACCINE COMPOSITIONS | |
| RU99114027A (en) | HELICOBACTER PYLORY NUCLEIC ACID AND AMINO ACID SEQUENCES AND THEIR VACCINE COMPOSITIONS | |
| AU7537598A (en) | Dna based anti-(helicobacter) vaccine composition | |
| GB9610192D0 (en) | DNA vaccine formulations | |
| IL140354A0 (en) | 128 novel nucleic acid and amino acid sequences |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19990528 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: LT PAYMENT 19990528;LV PAYMENT 19990528;RO PAYMENT 19990528;SI PAYMENT 19990528 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ASTRAZENECA AB |
|
| RTI1 | Title (correction) |
Free format text: NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS THEREOF |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7G 01N 33/68 B Ipc: 7A 61K 48/00 B Ipc: 7A 61K 39/106 B Ipc: 7C 07K 19/00 B Ipc: 7C 12N 15/63 B Ipc: 7C 12Q 1/68 B Ipc: 7C 07K 14/205 B Ipc: 7C 12N 15/31 A |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20050215 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20050504 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1024597 Country of ref document: HK |